What types of cancer can 'MySignal Scan' detect?

It assesses the risk for 10 types of cancer, including pancreatic cancer. However, ovarian and breast cancer are for women only, and prostate cancer is for men only.

No, it involves only collecting urine, so there is minimal physical burden.

Can this test diagnose cancer?

No, this is a risk assessment test and not a substitute for a medical 'diagnosis.' A low risk does not rule out the possibility of cancer.

Which hospital has introduced this test?

Medical Excellence International General Hospital's SOPHIA Health Check-up. It is offered as an option for health check-ups.

What are Craif's technological strengths?

Their strength lies in combining proprietary 'NANO IP®︎' technology for high-precision detection of microRNAs in urine with AI to aim for ultra-early cancer detection.

AI News NQ Analysis

Craif's Urine Cancer Risk Test 'MySignal Scan' Introduced at Medical Excellence International General Hospital's SOPHIA Health Check-up

Key facts

Craif's Urine Cancer Risk Test 'MySignal Scan' Introduced at Medical Excellence International General Hospital's SOPHIA Health Check-up
Craif Inc., a bio-AI startup, announces that its urine cancer risk test, 'MySignal Scan,' will be newly introduced as an optional examination for health check-ups at Medical Excellence International General Hospital's SOPHIA Health Check-up. This introduction aims to expand less physically burdensome testing options, lower the barrier to undergoing screenings, and contribute to cancer prevention and early detection.
Source: PR TIMES
Date: Wed Jun 10 2026 10:00:02 GMT+0900 (Japan Standard Time)

Direct answer

Craif Inc., a bio-AI startup, announces that its urine cancer risk test, 'MySignal Scan,' will be newly introduced as an optional examination for health check-ups at Medical Excellence International General Hospital's SOPHIA Health Check-up. This introduction aims to expand less physically burdensome testing options, lower the barrier to undergoing screenings, and contribute to cancer prevention and early detection.

Citation: Craif's Urine Cancer Risk Test 'MySignal Scan' Introduced at Medical Excellence International General Hospital's SOPHIA Health Check-up (Wed Jun 10 2026 10:00:02 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Wed Jun 10 2026 10:00:02 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Craif Inc., a bio-AI startup, announces that its urine cancer risk test, 'MySignal Scan,' will be newly introduced as an optional examination for health check-ups at Medical Excellence International General Hospital's SOPHIA Health Check-up. This introduction aims to expand less physically burdensome testing options, lower the barrier to undergoing screenings, and contribute to cancer prevention and early detection.

AI Analysis

Frequently Asked Questions

Q: What types of cancer can 'MySignal Scan' detect?: A: It assesses the risk for 10 types of cancer, including pancreatic cancer. However, ovarian and breast cancer are for women only, and prostate cancer is for men only.
Q: Is the test painful?: A: No, it involves only collecting urine, so there is minimal physical burden.
Q: Can this test diagnose cancer?: A: No, this is a risk assessment test and not a substitute for a medical 'diagnosis.' A low risk does not rule out the possibility of cancer.
Q: Which hospital has introduced this test?: A: Medical Excellence International General Hospital's SOPHIA Health Check-up. It is offered as an option for health check-ups.
Q: What are Craif's technological strengths?: A: Their strength lies in combining proprietary 'NANO IP®︎' technology for high-precision detection of microRNAs in urine with AI to aim for ultra-early cancer detection.